Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis (Q40965602)

25 September 2017

Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis (English)

1 reference

25 September 2017

metastatic breast cancer

1 reference

3

Markus Wallwiener

0 references

Manuela Zucknick

4

Manuela Zucknick

0 references

Jenny Chang-Claude

12

Jenny Chang-Claude

1 reference

25 September 2017

14

Barbara Burwinkel

0 references

Sarah Schott

Sarah Schott

6

0 references

Andreas Trumpp

Andreas Trumpp

9

0 references

Andreas Schneeweiss

13

Andreas Schneeweiss

1 reference

25 September 2017

7

Anja Rudolph

1 reference

25 September 2017

Dharanija Madhavan

1

1 reference

25 September 2017

Cike Peng

2

1 reference

25 September 2017

Markus Wallwiener

3

1 reference

25 September 2017

Manuela Zucknick

4

1 reference

25 September 2017

Juliane Nees

5

1 reference

25 September 2017

Sabine Riethdorf

8

1 reference

25 September 2017

Klaus Pantel

10

1 reference

25 September 2017

Christof Sohn

11

1 reference

25 September 2017

language of work or name

English

0 references

publication date

19 January 2016

1 reference

25 September 2017

1 reference

25 September 2017

37

1 reference

25 September 2017

5

1 reference

25 September 2017

461-470

1 reference

25 September 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Technologies for detection of circulating tumor cells: facts and vision

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Prognostic factors in 1,038 women with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Prognostic factors and survival in metastatic breast cancer: A single institution experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Characterization of extracellular circulating microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Circulating microRNAs in plasma as early detection markers for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Serum circulating microRNA profiling for identification of potential breast cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Plasma microRNA panel for minimally invasive detection of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Bioconductor: open software development for computational biology and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

miR-200 enhances mouse breast cancer cell colonization to form distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Comparing the MicroRNA spectrum between serum and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

Detection and Characterization of Placental MicroRNAs in Maternal Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGW008

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGW008

1 reference

25 September 2017

1 reference